SCHEMBL5731402

SCHEMBL5731402

CCOC(=O)c1cc(CC(C)C)sc1Sc1ccccc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.50
MAPK1 P28482 3/20 0.50
POLB P06746 2/20 0.50
HSD17B10 Q99714 4/20 0.47
GAA P10253 4/20 0.43
MAPT P10636 9/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 2/20 0.42
NPC1 O15118 2/20 0.42
KMT2A Q03164 2/20 0.42
ALOX15 P16050 2/20 0.42
TSHR P16473 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
PKM P14618 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5731900 0.82 ALDH1A1 (0.54) ALDH1A1MAPK1POLBHSD17B10GAA
SCHEMBL1604941 0.76 GAA (0.73) ALDH1A1MAPK1POLBHSD17B10GAA
SCHEMBL9131623 0.74 ALDH1A1 (0.69) ALDH1A1MAPK1POLBHSD17B10GAA
SCHEMBL5731957 0.74 ALDH1A1 (0.43) ALDH1A1MAPK1POLBHSD17B10GAA
SCHEMBL5732119 0.72 ALDH1A1 (0.54) ALDH1A1MAPK1POLBHSD17B10MAPT
SCHEMBL5731992 0.71 ALDH1A1 (0.55) ALDH1A1MAPK1POLBHSD17B10MAPT
SCHEMBL3099361 0.71 GAA (0.52) ALDH1A1MAPK1POLBGAAMAPT
SCHEMBL5732298 0.71 GAA (0.49) ALDH1A1MAPK1POLBHSD17B10GAA
SCHEMBL1568828 0.70 ALDH1A1 (0.56) ALDH1A1MAPK1POLBHSD17B10GAA
SCHEMBL5732391 0.70 ALDH1A1 (0.56) ALDH1A1MAPK1POLBHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270656-A1 Substituted piperazines of azepines, oxazepines and thiazepines ELI LILLY AND COMPANY 2006-11-30 US disclosed
EP-1664063-A1 SUBSTITUTED PIPERAZINES OF AZEPINES, OXAZEPINES, AND THIAZEPINES ELI LILLY AND COMPANY (US) 2006-06-07 EP disclosed
WO-2005026177-A1 SUBSTITUTED PIPERAZINES OF AZEPINES, OXAZEPINES, AND THIAZEPINES ELI LILLY AND COMPANY (US) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270656-A1 Substituted piperazines of azepines, oxazepines and thiazepines HRH4, HRH2, HRH3 ALDH1A1 2523/4885MAPK1 3789/4885POLB 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.